Bryn Mawr, PA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)The Sharpe - Strumia Research Foundation of the Bryn Mawr Hospital, founded in 2004, is a community nonprofit in the Diseases & Disorders sector that reported $1.2M in total revenue in fiscal year 2023. Revenue surged 22% from the prior year, signaling strong growth momentum. The organization ran a surplus of $198K, a strong 16% operating margin.
THE MISSION OF THE SHARPE-STRUMIA RESEARCH FOUNDATION IS TO SUPPORT AND CARRY OUT THE MISSIONS OF THE MAIN LINE HOSPITALS BY ENCOURAGING AND SUPPORTING THE CONDUCT OF MEDICAL RESEARCH BY PRACTICING PHYSICIANS ON THE MEDICAL STAFF AT MAIN LINE HOSPITALS WITH PREFERENCE GIVEN TO PHYSICIANS WHOSE PRIMARY HOSPITAL AFFILIATION IS THE BRYN MAWR CAMPUS AND TO RESEARCH WHICH RELATES TO IDENTIFIED CLINICAL INITIATIVES AT BRYN MAWR HOSPITAL OR OTHER MAIN LINE HOSPITALS.
THE FOUNDATION FUNDED 16 GRANTS FOR MEDICAL RESEARCH ACCORDING TO ITS MISSION STATEMENT. EACH RESEARCH GRANT WAS MONITORED BY THE FOUNDATION'S SCIENTIFIC COMMITTEE TO INSURE THE INVESTIGATORS WERE...
THE FOUNDATION FUNDED 16 GRANTS FOR MEDICAL RESEARCH ACCORDING TO ITS MISSION STATEMENT. EACH RESEARCH GRANT WAS MONITORED BY THE FOUNDATION'S SCIENTIFIC COMMITTEE TO INSURE THE INVESTIGATORS WERE PROPERLY EXPENSING THEIR GRANTS AND THE INVESTIGATORS DID SUBMIT PROGRESS REPORTS FOR THE COMMITTEE TO MONITOR, THESE RESEARCH PROGRAMS ALLOW THE ADVANCEMENT OF MEDICAL KNOWLEDGE.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $1,213,481 | $996,815 | +0.2% |
| Expenses | $1,015,378 | $935,371 | +0.1% |
| Net Income | $198,103 | $61,444 | +2.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| NED CARP MD | Director | 1.0 |
Director
|
$0 | $39,062 | $1,082,057 |
| John T Schwarz | DIRECTOr | 1.0 |
Director
|
$0 | $131,500 | $854,237 |
| Jeffery Wise | DIRECTOR | 1.0 |
Director
|
$0 | $42,445 | $270,639 |
| LOUISE GETHERS | DIRECTOR, ADMIN ASST | 40.0 |
Director
|
$59,305 | $12,741 | $72,046 |
| Jack L Martin MD | PRESIDENT | 5.0 |
Officer
Director
|
$22,160 | $0 | $22,160 |
| BArbara S Lindsay RN | TREASURER/SECRETARY | 1.0 |
Officer
Director
|
$16,901 | $0 | $16,901 |
| GUY BERNSTEIN MD | VICE PRESIDENT | 1.0 |
Officer
Director
|
$0 | $0 | $0 |
| GARY Friday MD | DIRECTOR | 1.0 |
Director
|
$0 | $0 | $0 |
| HANS Liu MD | DIRECTOR | 1.0 |
Director
|
$0 | $0 | $0 |
| JAMES Mullin PhD | Director | 1.0 |
Director
|
$0 | $0 | $0 |
| LAWRENCE LIVORNESE JR MD | DIRECTOR | 1.0 |
Director
|
$0 | $0 | $0 |
| miCHELE COLUMBO | DIRECTOR | 1.0 |
Director
|
$0 | $0 | $0 |
| Scott K Dessain MD PhD | Designee for Larry Livornese | 1.0 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | $1,213,481 | $1,015,378 | $24,560,991 | $198,103 |
| 2023 | $996,815 | $935,371 | $22,459,181 | $61,444 |
| 2022 | $1,098,202 | $952,191 | $20,997,404 | $146,011 |
| 2021 | $1,417,708 | $1,036,019 | $25,307,489 | $381,689 |
| 2020 | $1,169,588 | $860,556 | $20,791,061 | $309,032 |
| 2019 | $698,763 | $651,785 | $20,200,789 | $46,978 |
| 2018 | $898,116 | $772,218 | $19,499,070 | $125,898 |
Compare The Sharpe - Strumia Research Foundation of the Bryn Mawr Hospital with other nonprofits in Pennsylvania and across the country.